PsychedelicNewsBreaks – Hemptown USA Strategically Positioned to Become Largest North American Producer of CBD

Hemptown USA, a privately owned grower of full-spectrum, feminized hemp using premium-seed genetics, operates a farm operation with more than 500 acres dedicated to the cultivation of nonpsychoactive cannabigerol (“CBG”). The company’s recent harvest positioned it to be the largest producer of CBG in North America. An article discussing the company reads, “Hemptown USA has built CBD production from broad-spectrum hemp biomass in states such as Oregon, Kentucky and California, but has worked to increase its profile as hemp-friendly laws have been enacted — particularly last year’s farm bill that legalized commercial hemp cultivation nationwide following years of prohibition. . . . The company’s focus on its CBG-growing resources is part of an ongoing effort to serve an increasingly health-conscious society’s desire for wellness based on natural elements with minimal pharmaceutical involvement.”

To view the full article, visit http://cnw.fm/YmZO0

About Hemptown USA

Hemptown USA is growing some of the finest high-cannabinoid hemp plants in the world. Following an impressive first-year yield, Hemptown USA is scaling up its operation to meet the ever-increasing global demand for cannabinoid products. With expanded farmland spanning three states and in-house extraction and processing facilities, Hemptown USA is now positioned to vertically integrate into the Consumer Packaged Goods sectors with top-quality-branded product lines for the consumer market. Hemptown USA’s vertically integrated business model is well positioned to capitalize on a global market expected to exceed $22 billion by 2020. For more information, visit the company’s website at www.HemptownUSA.com.

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing PsychedelicNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. PNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. PsychedelicNewsWire (PNW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have a questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Chris@PNW

Share
Published by
Chris@PNW

Recent Posts

PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) CEO to Join Fireside Chat at BTIG Virtual Biotechnology Conference

NRx Pharmaceuticals (NASDAQ: NRXP), announced that CEO and Chairman Prof. Jonathan Javitt, MD, MPH will…

2 days ago

PsychedelicNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Charts Dual-Path for NRX-100 

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing innovative treatments for suicidal depression and…

2 weeks ago

PsychedelicNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Positioning at the Forefront of Next-Gen Treatment

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, is executing a dual growth strategy focused…

2 weeks ago

PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire 49% Stake in Leading Florida Psychiatry Clinic

NRx Pharmaceuticals (NASDAQ: NRXP), via its wholly owned subsidiary HOPE Therapeutics(TM), Inc., has signed a…

1 month ago

PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Taps IBN to Lead Corporate Communications Amid Drug Advancements and Subsidiary Launch

NRx Pharmaceuticals (NASDAQ: NRXP) a clinical-stage biopharmaceutical company developing innovative treatments for suicidal depression and…

1 month ago

PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s Priority Voucher for NRX-100 Ketamine Formulation

NRx Pharmaceuticals (NASDAQ: NRXP) has filed for the newly launched FDA Commissioner’s National Priority Voucher…

1 month ago